Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?
Open Access
- 3 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Pathology and Oncology Research
- Vol. 27, 643146
Abstract
Cells of the monocyte macrophage lineage form multinucleated giant cells (GCs) by fusion, which may express some cell cycle markers. By using a comprehensive marker set, here we looked for potential replication activities in GCs, and investigated whether these have diagnostic or clinical relevance in giant cell tumor of bone (GCTB). GC rich regions of 10 primary and 10 first recurrence GCTB cases were tested using immunohistochemistry in tissue microarrays. The nuclear positivity rate of the general proliferation marker, replication licensing, G1/S-phase, S/G2/M-phase, mitosis promoter, and cyclin dependent kinase (CDK) inhibitor reactions was analyzed in GCs. Concerning Ki67, moderate SP6 reaction was seen in many GC nuclei, while B56 and Mib1 positivity was rare, but the latter could be linked to more aggressive (p = 0.012) phenotype. Regular MCM6 reaction, as opposed to uncommon MCM2, suggested an initial DNA unwinding. Early replication course in GCs was also supported by widely detecting CDK4 and cyclin E, for the first time, and confirming cyclin D1 upregulation. However, post-G1-phase markers CDK2, cyclin A, geminin, topoisomerase-2a, aurora kinase A, and phospho-histone H3 were rare or missing. These were likely silenced by upregulated CDK inhibitors p15INK4b, p16INK4a, p27KIP1, p53 through its effector p21WAF1 and possibly cyclin G1, consistent with the prevention of DNA replication. In conclusion, the upregulation of known and several novel cell cycle progression markers detected here clearly verify early replication activities in GCs, which are controlled by cell cycle arresting CDK inhibitors at G1 phase, and support the functional maturation of GCs in GCTB.Keywords
This publication has 52 references indexed in Scilit:
- Giant cell tumor of bone: A basic science perspectiveBone, 2013
- The Eukaryotic Mcm2-7 Replicative Helicase2012
- Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of boneHistopathology, 2011
- Frequent Upregulation of Cyclin D1 and p16INK4a Expression with Low Ki-67 Scores in Multinucleated Giant CellsPathobiology, 2011
- The immunophenotype of osteoclasts and macrophage polykaryonsJournal of Clinical Pathology, 2011
- p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted TherapiesClinical Cancer Research, 2011
- Ki-67 immuno-histochemistry index in stage III giant cell tumor of the boneJournal of Experimental & Clinical Cancer Research, 2010
- Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferationJournal of Experimental & Clinical Cancer Research, 2009
- The proliferative human monocyte subpopulation contains osteoclast precursorsArthritis Research & Therapy, 2009
- Cyclin Alterations in Giant Cell Tumor of BoneLaboratory Investigation, 2003